Biogen Operating Income from 2010 to 2026

BIIB Stock

USD 185.45 8.69 4.92%

Biogen's Operating Income is increasing over the years with very volatile fluctuation. Operating Income is expected to dwindle to about 1.6 B. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Biogen Inc generates from its operations. View All Fundamentals

Operating Income

First Reported

1985-09-30

Previous Quarter

588.1 M

Current Value

613.8 M

Quarterly Volatility

532 M

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Biogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 812.9 M, Interest Expense of 302.2 M or Selling General Administrative of 2.8 B, as well as many indicators such as Price To Sales Ratio of 2.52, Dividend Yield of 0.0028 or PTB Ratio of 1.46. Biogen financial statements analysis is a perfect complement when working with Biogen Valuation or Volatility modules.

Build AI portfolio with Biogen Stock

Check out the analysis of Biogen Correlation against competitors.

Analyzing Biogen's Operating Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Income has evolved provides context for assessing Biogen's current valuation and future prospects.

Latest Biogen's Operating Income Growth Pattern

Below is the plot of the Operating Income of Biogen Inc over the last few years. Operating Income is the amount of profit realized from Biogen Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Biogen Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Biogen's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biogen's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Biogen Operating Income Regression Statistics

	Arithmetic Mean	3,393,523,838
	Coefficient Of Variation	54.48
	Mean Deviation	1,544,756,840
	Median	2,863,845,000
	Standard Deviation	1,848,788,999
	Sample Variance	3418020.8T
	Range	7.1B
	R-Value	0.09
	Mean Square Error	3618184.1T
	R-Squared	0.01
	Significance	0.74
	Slope	31,914,843
	Total Sum of Squares	54688332.2T

Biogen Operating Income History

	2026	1.6 B
	2025	2.9 B
	2024	2.5 B
	2023	2.1 B
	2022	2.9 B
	2021	2.8 B
	2020	4.6 B

Other Fundumenentals of Biogen Inc

Non Operating Income Net Other

Biogen Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Investments	Common Stock	Short Term Debt	Long Term Debt	Property Plant Equipment	Current Deferred Revenue	Treasury Stock	Good Will	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.95	0.82	0.99	0.91	0.94	0.93	0.71	0.9	-0.01	-0.76	0.66	0.72	0.84	-0.35	-0.86	0.94	0.4	0.79	-0.92	0.34	-0.3	0.72	0.2	-0.5	-0.48
Total Stockholder Equity	0.95		0.63	0.96	0.82	0.79	0.84	0.84	0.79	-0.19	-0.75	0.7	0.5	0.73	-0.15	-0.76	0.86	0.57	0.6	-0.76	0.19	-0.39	0.71	0.28	-0.52	-0.6
Net Debt	0.82	0.63		0.78	0.71	0.92	0.76	0.45	0.73	0.16	-0.56	0.38	0.91	0.76	-0.37	-0.74	0.82	0.06	0.93	-0.92	0.26	-0.17	0.5	0.19	-0.43	-0.25
Retained Earnings	0.99	0.96	0.78		0.86	0.91	0.92	0.75	0.84	-0.06	-0.7	0.67	0.69	0.79	-0.28	-0.84	0.94	0.48	0.78	-0.89	0.27	-0.29	0.71	0.21	-0.49	-0.52
Net Receivables	0.91	0.82	0.71	0.86		0.89	0.86	0.47	0.9	0.1	-0.76	0.57	0.68	0.89	-0.54	-0.9	0.86	0.3	0.68	-0.83	0.56	-0.26	0.66	0.04	-0.34	-0.28
Total Liab	0.94	0.79	0.92	0.91	0.89		0.92	0.49	0.9	0.19	-0.69	0.55	0.86	0.87	-0.51	-0.87	0.91	0.19	0.89	-0.97	0.46	-0.17	0.65	0.11	-0.42	-0.31
Total Current Assets	0.93	0.84	0.76	0.92	0.86	0.92		0.47	0.87	0.27	-0.77	0.48	0.79	0.83	-0.37	-0.89	0.84	0.38	0.82	-0.94	0.3	0.02	0.52	-0.08	-0.2	-0.32
Intangible Assets	0.71	0.84	0.45	0.75	0.47	0.49	0.47		0.46	-0.57	-0.45	0.65	0.2	0.37	0.17	-0.42	0.66	0.53	0.36	-0.46	-0.06	-0.63	0.65	0.6	-0.72	-0.71
Accounts Payable	0.9	0.79	0.73	0.84	0.9	0.9	0.87	0.46		0.04	-0.72	0.6	0.67	0.86	-0.57	-0.83	0.89	0.24	0.71	-0.84	0.46	-0.28	0.66	0.0	-0.38	-0.34
Short Term Investments	-0.01	-0.19	0.16	-0.06	0.1	0.19	0.27	-0.57	0.04		-0.26	-0.32	0.42	0.21	-0.29	-0.25	-0.16	-0.35	0.27	-0.29	0.21	0.82	-0.3	-0.41	0.51	0.45
Common Stock	-0.76	-0.75	-0.56	-0.7	-0.76	-0.69	-0.77	-0.45	-0.72	-0.26		-0.33	-0.56	-0.77	0.16	0.79	-0.54	-0.24	-0.53	0.73	-0.18	0.02	-0.35	-0.05	0.22	0.2
Short Term Debt	0.66	0.7	0.38	0.67	0.57	0.55	0.48	0.65	0.6	-0.32	-0.33		0.14	0.45	-0.46	-0.35	0.72	0.36	0.32	-0.45	0.48	-0.57	0.96	0.45	-0.68	-0.63
Long Term Debt	0.72	0.5	0.91	0.69	0.68	0.86	0.79	0.2	0.67	0.42	-0.56	0.14		0.81	-0.38	-0.79	0.68	0.1	0.96	-0.91	0.22	0.12	0.26	-0.06	-0.15	0.06
Property Plant Equipment	0.84	0.73	0.76	0.79	0.89	0.87	0.83	0.37	0.86	0.21	-0.77	0.45	0.81		-0.49	-0.88	0.79	0.35	0.81	-0.87	0.39	-0.15	0.52	0.09	-0.35	-0.02
Current Deferred Revenue	-0.35	-0.15	-0.37	-0.28	-0.54	-0.51	-0.37	0.17	-0.57	-0.29	0.16	-0.46	-0.38	-0.49		0.39	-0.46	0.13	-0.35	0.42	-0.79	0.13	-0.49	0.08	0.11	-0.09
Treasury Stock	-0.86	-0.76	-0.74	-0.84	-0.9	-0.87	-0.89	-0.42	-0.83	-0.25	0.79	-0.35	-0.79	-0.88	0.39		-0.75	-0.28	-0.77	0.88	-0.32	0.04	-0.43	0.0	0.25	0.08
Good Will	0.94	0.86	0.82	0.94	0.86	0.91	0.84	0.66	0.89	-0.16	-0.54	0.72	0.68	0.79	-0.46	-0.75		0.4	0.78	-0.85	0.39	-0.44	0.79	0.19	-0.54	-0.5
Net Tangible Assets	0.4	0.57	0.06	0.48	0.3	0.19	0.38	0.53	0.24	-0.35	-0.24	0.36	0.1	0.35	0.13	-0.28	0.4		0.2	-0.23	-0.14	-0.22	0.24	0.16	-0.2	-0.2
Long Term Debt Total	0.79	0.6	0.93	0.78	0.68	0.89	0.82	0.36	0.71	0.27	-0.53	0.32	0.96	0.81	-0.35	-0.77	0.78	0.2		-0.93	0.19	-0.02	0.43	0.07	-0.33	-0.1
Capital Surpluse	-0.92	-0.76	-0.92	-0.89	-0.83	-0.97	-0.94	-0.46	-0.84	-0.29	0.73	-0.45	-0.91	-0.87	0.42	0.88	-0.85	-0.23	-0.93		-0.34	0.03	-0.53	-0.05	0.32	0.22
Deferred Long Term Liab	0.34	0.19	0.26	0.27	0.56	0.46	0.3	-0.06	0.46	0.21	-0.18	0.48	0.22	0.39	-0.79	-0.32	0.39	-0.14	0.19	-0.34		-0.15	0.53	0.04	-0.19	0.01
Long Term Investments	-0.3	-0.39	-0.17	-0.29	-0.26	-0.17	0.02	-0.63	-0.28	0.82	0.02	-0.57	0.12	-0.15	0.13	0.04	-0.44	-0.22	-0.02	0.03	-0.15		-0.62	-0.51	0.71	0.45
Short Long Term Debt	0.72	0.71	0.5	0.71	0.66	0.65	0.52	0.65	0.66	-0.3	-0.35	0.96	0.26	0.52	-0.49	-0.43	0.79	0.24	0.43	-0.53	0.53	-0.62		0.44	-0.74	-0.62
Net Invested Capital	0.2	0.28	0.19	0.21	0.04	0.11	-0.08	0.6	0.0	-0.41	-0.05	0.45	-0.06	0.09	0.08	0.0	0.19	0.16	0.07	-0.05	0.04	-0.51	0.44		-0.86	-0.29
Net Working Capital	-0.5	-0.52	-0.43	-0.49	-0.34	-0.42	-0.2	-0.72	-0.38	0.51	0.22	-0.68	-0.15	-0.35	0.11	0.25	-0.54	-0.2	-0.33	0.32	-0.19	0.71	-0.74	-0.86		0.42
Capital Stock	-0.48	-0.6	-0.25	-0.52	-0.28	-0.31	-0.32	-0.71	-0.34	0.45	0.2	-0.63	0.06	-0.02	-0.09	0.08	-0.5	-0.2	-0.1	0.22	0.01	0.45	-0.62	-0.29	0.42

Click cells to compare fundamentals

About Biogen Financial Statements

Biogen stakeholders use historical fundamental indicators, such as Biogen's Operating Income, to determine how well the company is positioned to perform in the future. Although Biogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biogen's assets and liabilities are reflected in the revenues and expenses on Biogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biogen Inc. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	2.9 B	1.6 B
Non Operating Income Net Other	706.7 M	742 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen

Details

Is Biogen Stock a good investment?

Details

What is Biogen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Biogen Correlation against competitors.

You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. Projected growth potential of Biogen fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Biogen assessment requires weighing all these inputs, though not all factors influence outcomes equally.

Quarterly Earnings Growth

0.192

Earnings Share

10.98

Revenue Per Share

68.815

Quarterly Revenue Growth

0.028

Return On Assets

0.0575

Biogen Inc's market price often diverges from its book value, the accounting figure shown on Biogen's balance sheet. Smart investors calculate Biogen's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Biogen's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

It's important to distinguish between Biogen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biogen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Biogen Operating Income from 2010 to 2026

Latest Biogen's Operating Income Growth Pattern

Biogen Operating Income Regression Statistics

Biogen Operating Income History

Other Fundumenentals of Biogen Inc

Biogen Operating Income component correlations

About Biogen Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY